The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., & Hemminki, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007133430201 · Cited by 4,114
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Harvey, J. M., Clark, G. M., Osborne, C. K., & Allred, D. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1474 · Cited by 2,056
Polychemotherapy for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(98)03301-7 · Cited by 2,042
Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer
Hartmann, L. C., Schaid, D. J., Woods, J. E., Crotty, T. P., Myers, J. L., Arnold, P. G., Petty, P. M., Sellers, T. A., Johnson, J. L., McDonnell, S. K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400201 · Cited by 1,423
Bonadonna, G., Valagussa, P., Moliterni, A., Zambetti, M., & Brambilla, C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321401 · Cited by 1,049
Fisher, B., Dignam, J., Wolmark, N., Wickerham, D. L., Fisher, E. R., Mamounas, E., Smith, R., Begovic, M., Dimitrov, N. V., Margolese, R. G., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05036-9 · Cited by 1,040
Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer
Early Breast Cancer Trialists' Collaborative Group (1988) · New England Journal of Medicine · doi:10.1056/nejm198812293192601 · Cited by 933
Powles, T. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05071-5 · Cited by 902
Fisher, B., Dignam, J., Wolmark, N., Mamounas, E., Costantino, J., Poller, W., Fisher, E. R., Wickerham, D. L., Deutsch, M., Margolese, R., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.441 · Cited by 894
Veronesi, U. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04394-3 · Cited by 804
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
Goldhirsch, A., Wood, W. C., Senn, H.-J., Glick, J. H., & Gelber, R. D. (1995) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/87.19.1441 · Cited by 689
Self-citationThe Influence of Margin Width on Local Control of Ductal Carcinoma in Situ of the Breast
Silverstein, M. J., Lagios, M. D., Groshen, S., Waisman, J. R., Lewinsky, B. S., Martino, S., Gamagami, P., & Colburn, W. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401902 · Cited by 673
Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers
Rebbeck, T. R., Levin, A. M., Eisen, A., Snyder, C., Watson, P., Cannon-Albright, L., Isaacs, C., Olopade, O., Garber, J. E., Godwin, A. K., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.17.1475 · Cited by 672
Levine, M. N., Bramwell, V. H., Pritchard, K. I., Norris, B. D., Shepherd, L. E., Abu-Zahra, H., Findlay, B., Warr, D., Bowman, D., Myles, J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2651 · Cited by 617
Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
Wood, W. C., Budman, D. R., Korzun, A. H., Cooper, M. R., Younger, J., Hart, R. D., Moore, A., Ellerton, J. A., Norton, L., Ferree, C. R., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301801 · Cited by 577
Ovarian ablation in early breast cancer: overview of the randomised trials
(1996) · The Lancet · doi:10.1016/s0140-6736(96)05023-4 · Cited by 561
Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
(1994) · New England Journal of Medicine · doi:10.1056/nejm199407143310226 · Cited by 556
Narod, S. A., Brunet, J.-S., Ghadirian, P., Robson, M., Heimdal, K., Neuhausen, S. L., Stoppa-Lyonnet, D., Lerman, C., Pasini, B., de los Rios, P., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03258-x · Cited by 543
Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer
Fisher, B., Dignam, J., Emir, B., Bryant, J., DeCillis, A., Wolmark, N., Wickerham, D. L., Dimitrov, N. V., Abramson, N., Atkins, J. N., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.22.1673 · Cited by 521
Julien, J.-P., Bijker, N., Fentiman, I. S., Peterse, J. L., Delledonne, V., Rouanet, P., Avril, A., Sylvester, R., Mignolet, F., Bartelink, H., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06341-2 · Cited by 514
Fisher, E. R., Dignam, J., Tan-Chiu, E., Costantino, J., Fisher, B., Paik, S., Wolmark, N., & for the National Surgical Adjuvant Breast Bowel Project (NSABP) Collaborating Investigators (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990801)86:3<429::aid-cncr11>3.0.co;2-y · Cited by 500
Schrag, D., Kuntz, K. M., Garber, J. E., & Weeks, J. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362022 · Cited by 435
Klijn, J. G. M., Blamey, R. W., Boccardo, F., Tominaga, T., Duchateau, L., & Sylvester, R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.343 · Cited by 425
Veronesi, U., De Palo, G., Marubini, E., Costa, A., Formelli, F., Mariani, L., Decensi, A., Camerini, T., Del Turco, M. R., Di Mauro, M. G., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.21.1847 · Cited by 419
Cauley, J. A., Lucas, F. L., Kuller, L. H., Stone, K., Browner, W., Cummings, S. R., & for the Study of Osteoporotic Fractures Research Group (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-4_part_1-199902160-00004 · Cited by 409
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
Goldhirsch, A., Glick, J. H., Gelber, R. D., & Senn, H.-J. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.21.1601 · Cited by 380
Self-citationSelective Estrogen Receptor Modulators: Structure, Function, and Clinical Use
Osborne, C. K., Zhao, H. (., & Fuqua, S. A. W. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3172 · Cited by 367
Bergh, J., Wiklund, T., Erikstein, B., Lidbrink, E., Lindman, H., Malmström, P., Kellokumpu-Lehtinen, P., Bengtsson, N.-O., Söderlund, G., Anker, G., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02841-5 · Cited by 339
Paszat, L. F., Mackillop, W. J., Groome, P. A., Boyd, C., Schulze, K., & Holowaty, E. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2625 · Cited by 302
Lindley, C., Vasa, S., Sawyer, W. T., & Winer, E. P. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1380 · Cited by 296
Fisher, B., Anderson, S., Tan-Chiu, E., Wolmark, N., Wickerham, D. L., Fisher, E. R., Dimitrov, N. V., Atkins, J. N., Abramson, N., Merajver, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.931 · Cited by 272
Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy.
Ravdin, P. M., Siminoff, I. A., & Harvey, J. A. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.515 · Cited by 262
By the French Adjuvant Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.602 · Cited by 252
Pagani, O., O’Neill, A., Castiglione, M., Gelber, R. D., Goldhirsch, A., Rudenstam, C.-M., Lindtner, J., Collins, J., Crivellari, D., Coates, A., et al. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10036-3 · Cited by 227
Self-citationLearning sentinel node biopsy: Results of a prospective randomized trial of two techniques
Morrow, M., Rademaker, A. W., Bethke, K. P., Talamonti, M. S., Dawes, L. G., Clauson, J., & Hansen, N. (1999) · Surgery · doi:10.1016/s0039-6060(99)70127-3 · Cited by 215
Colleoni, M., Bonetti, M., Coates, A. S., Castiglione-Gertsch, M., Gelber, R. D., Price, K., Rudenstam, C.-M., Lindtner, J., Collins, J., Thürlimann, B., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.584 · Cited by 197
Self-citationLessons learned from BRCA1 and BRCA2
Zheng, L., Li, S., Boyer, T. G., & Lee, W.-H. (2000) · Oncogene · doi:10.1038/sj.onc.1203968 · Cited by 188
Zambetti, M., Moliterni, A., Materazzo, C., Stefanelli, M., Cipriani, S., Valagussa, P., Bonadonna, G., & Gianni, L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.37 · Cited by 186
Quality-of-Life Scores Predict Outcome in Metastatic but Not Early Breast Cancer
Coates, A. S., Hürny, C., Peterson, H. F., Bernhard, J., Castiglione-Gertsch, M., Gelber, R. D., Goldhirsch, A., & for the International Breast Cancer Study Group (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3768 · Cited by 181
Self-citationHamilton, A., & Piccart, M. (2000) · Annals of Oncology · doi:10.1023/a:1008390429428 · Cited by 174
Fisher, B., Dignam, J., Tan-Chiu, E., Anderson, S., Fisher, E. R., Wittliff, J. L., & Wolmark, N. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.2.112 · Cited by 166
International Breast Cancer Study Group (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1385 · Cited by 113
Bentrem, D. J., Dardes, R. C., Liu, H., Schafer, J. M., Zapf, J. W., & Jordan, V. C. (2001) · Endocrinology · doi:10.1210/endo.142.2.7932 · Cited by 102
Southey, M., Tesoriero, A., Andersen, C. R., Jennings, K. M., Brown, S., Dite, G., Jenkins, M., Osborne, R., Maskiell, J., Porter, L., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690008 · Cited by 98
Serum oestradiol and breast cancer risk.
Key, T. J. (1999) · Endocrine Related Cancer · doi:10.1677/erc.0.0060175 · Cited by 98
Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers
Rebbeck, T. R. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00269-1 · Cited by 95
Jakesz, R., Hausmaninger, H., Samonigg, H., et al. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)80701-1 · Cited by 72
Endocrine profile in breast cancer patients receiving chemotherapy
Mehta, R. R., Beattie, C. W., & Gupta, T. K. D. (1991) · Breast Cancer Research and Treatment · doi:10.1007/bf01834642 · Cited by 61
Eeles, R. (2000) · Breast Cancer Research · doi:10.1186/bcr70 · Cited by 32
HER-2 as a Prognostic, Predictive, and Therapeutic Target in Breast Cancer
Perez, E. A. (1999) · Cancer Control · doi:10.1177/107327489900600301 · Cited by 23
Cited by
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Breast cancer metastasis: markers and models
Weigelt, B., Peterse, J. L., & van't Veer, L. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1670 · Cited by 2,232
Pawitan, Y., Bjöhle, J., Amler, L., Borg, A.-L., Egyhazi, S., Hall, P., Han, X., Holmberg, L., Huang, F., Klaar, S., et al. (2005) · Breast Cancer Research · doi:10.1186/bcr1325 · Cited by 831
Breast Cancer Before Age 40 Years
Anders, C. K., Johnson, R., Litton, J., Phillips, M., & Bleyer, A. (2009) · Seminars in Oncology · doi:10.1053/j.seminoncol.2009.03.001 · Cited by 791
Metadata
- Authors
- Goldhirsch, A., Glick, J. H., Gelber, R. D., Coates, A. S., & Senn, H.-J.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-09-15
- Volume
- 19
- Issue
- 18
- Pages
- 3817-3827
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1492893697
- Cited by
- 582
- References
- 54
- FWCI
- 23.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.